HUMACYTE INC (HUMA) Institutional Ownership
None of the superinvestors we track currently report HUMACYTE INC (HUMA) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in HUMACYTE INC (HUMA), this page will show disclosed ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q2 2024 | 1 | $2,881,440 | 600,300 |
| Q1 2024 | 1 | $235 | 75,700 |
| Q4 2023 | 1 | $270 | 95,100 |
| Q3 2023 | 1 | $315 | 107,500 |
| Q2 2023 | 1 | $205 | 71,600 |
| Q1 2023 | 1 | $147 | 47,700 |
| Q4 2022 | 1 | $50 | 23,800 |
| Q3 2022 | 1 | $678 | 208,000 |
| Q2 2022 | 1 | $36 | 11,100 |
| Q1 2022 | 1 | $333 | 47,100 |
| Q4 2021 | 1 | $107 | 14,800 |
Related HUMA Institutional Insights:
- HUMA Institutional Ownership & Insiders Activity
- HUMA Institutional Ownership & 13F Activity
- HUMA Top Institutional Shareholders
- HUMA Institutional Buying Activity
- HUMA Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- HUMA Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings